The event is a series of one-to-one meetings with investors.
The meeting is scheduled for September 3, 2026. The mode is Physical and the location is Mumbai. The specific time was not disclosed.
The stated purpose is for the company's officials to participate in meetings with investors.
The document does not specify if the meeting is scheduled before or after an earnings announcement.
Management participants and their designations were not provided in the disclosure.
The company stated that relevant Press Releases and Investor Presentations proposed to be discussed are available on the company's website (www.fermentabiotech.com) and on stock exchange websites.
The company explicitly stated that no unpublished price sensitive information (UPSI) is intended to be discussed during the interactions.
Additional Notes Section
The disclosure is a regulatory filing made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
The document includes a note that changes to the schedule may occur due to exigencies on the part of the company or the investors.
No financial data, guidance references, or presentation summaries were disclosed in this announcement.
The letter was digitally signed by Varadvinayak Vijay Khambete, Company Secretary & Head – Legal (Membership No. A33861).
